You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/08/19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
71 |
| 08/08/19 | 8-K | Current report filing |
|
9 | |
| 07/16/19 | DEF 14A | Definitive proxy statements |
|
45 | |
| 07/08/19 | 8-K | Current report filing |
|
6 | |
| 07/01/19 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
45 | |
| 06/12/19 | 8-K/A | Current report filing |
|
4 | |
| 06/07/19 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
11 | |
| 06/07/19 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/06/19 | 8-K | Current report filing |
|
25 | |
| 06/05/19 | 8-K | Current report filing |
|
4 |
